FWP Forward Pharma ADRs

Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$7.36  -0.04 (-0.54%)
As of 05/10/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Denmark
Country of incorporation:  Faroe Islands
IPO date:  10/15/2014
Outstanding shares:  6,891,971
Average volume:  36,027
Market cap:   $51,000,585
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    34986J105
ISIN:        US34986J1051
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.63
PS ratio:   0.00
Return on equity:   -10.05%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy